OptiNose, Inc. (OPTN)

OptiNose Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-30.76	-35.48	-74.83	-82.3	-99.79	-110.05
Depreciation & Amortization	0.41	0.4	0.53	0.65	1.46	1.11
Share-Based Compensation	5.13	5.2	8.88	10	10.35	9.86
Other Operating Activities	-6.87	9.35	-2.23	-5.29	1.77	8.27
Operating Cash Flow	-32.08	-20.53	-67.65	-76.94	-86.21	-90.82
Capital Expenditures	-0.35	-0.33	-0.06	-0.06	-0.55	-0.56
Investing Cash Flow	-0.35	-0.33	-0.06	-0.06	-0.55	-0.56
Share Issuance / Repurchase	0.14	0.3	51.73	43.55	34.69	45.89
Debt Issued / Paid	0	0	0	0	50	-2.58
Other Financing Activities	0.01	-	-0.3	-0.23	-0.88	-5.78
Financing Cash Flow	0.15	0.3	51.44	43.32	83.81	37.53
Exchange Rate Effect	0	0	0.01	0.01	-0.04	-0
Net Cash Flow	-32.28	-20.56	-16.27	-33.66	-2.99	-53.85
Free Cash Flow	-32.43	-20.86	-67.71	-77	-86.75	-91.37
Free Cash Flow Margin	-43.81%	-29.39%	-88.77%	-103.14%	-176.62%	-263.84%
Free Cash Flow Per Share	-0.29	-0.19	-0.79	-1.35	-1.80	-2.18

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).